Catheterization laboratory activity before and during COVID-19 spread: A comparative analysis in Piedmont, Italy, by the Italian Society of Interventional Cardiology (GISE).
COVID-19
GISE
Mitraclip
PCI
Piedmont
TAVR
Journal
International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291
Informations de publication
Date de publication:
15 01 2021
15 01 2021
Historique:
received:
29
04
2020
revised:
14
07
2020
accepted:
21
08
2020
pubmed:
29
8
2020
medline:
30
12
2020
entrez:
29
8
2020
Statut:
ppublish
Résumé
COronaVIrus Disease 19 (COVID-19) led to the reorganization of Cardiology Units in terms of working spaces and healthcare personnel. In this scenario, both outpatient visits and elective interventional cardiology procedures were suspended and/or postponed. We aimed to report the impact of COVID-19 on interventional coronary and structural procedures in Piedmont, Italy. The number of coronary angiographies (CAG), percutaneous coronary interventions (PCI), primary PCI (pPCI), transcatheter aortic valve replacements (TAVR) and Mitraclip performed in Piedmont between March 1st and April 20th, 2020 (CoV-time) were collected from each catheterization laboratory and compared to the number of procedures performed the year before in the same months (NoCoV-time). Procedural data from 18 catheterization laboratories were collected. Both coronary (5498 versus 2888: difference: -47.5%; mean 305.4 VS 160.4; p = 0.002) and structural (84 versus 17: difference: -79.8%; mean 4.7 Vs 0.9; p < 0.001) procedures decreased during CoV-time compared to NoCoV-time. In particular, coronary angiographies (1782 versus 3460), PCI (1074 versus 1983), p PCI (271 versus 410), TAVR (11 versus 72) and Mitraclip (6 versus 12) showed a reduction of 48.5%, 45.7%, 33.7%, 84.7% and 50.0%, respectively (all p for comparison <0.05). Compared to the same time-period in 2019, both coronary and structural interventional procedures during COVID-19 epidemic suffered a dramatic decrease in Piedmont, Italy. Organizational change and structured clinical pathways should be created, together with awareness campaigns.
Sections du résumé
BACKGROUND
COronaVIrus Disease 19 (COVID-19) led to the reorganization of Cardiology Units in terms of working spaces and healthcare personnel. In this scenario, both outpatient visits and elective interventional cardiology procedures were suspended and/or postponed. We aimed to report the impact of COVID-19 on interventional coronary and structural procedures in Piedmont, Italy.
METHODS
The number of coronary angiographies (CAG), percutaneous coronary interventions (PCI), primary PCI (pPCI), transcatheter aortic valve replacements (TAVR) and Mitraclip performed in Piedmont between March 1st and April 20th, 2020 (CoV-time) were collected from each catheterization laboratory and compared to the number of procedures performed the year before in the same months (NoCoV-time).
RESULTS
Procedural data from 18 catheterization laboratories were collected. Both coronary (5498 versus 2888: difference: -47.5%; mean 305.4 VS 160.4; p = 0.002) and structural (84 versus 17: difference: -79.8%; mean 4.7 Vs 0.9; p < 0.001) procedures decreased during CoV-time compared to NoCoV-time. In particular, coronary angiographies (1782 versus 3460), PCI (1074 versus 1983), p PCI (271 versus 410), TAVR (11 versus 72) and Mitraclip (6 versus 12) showed a reduction of 48.5%, 45.7%, 33.7%, 84.7% and 50.0%, respectively (all p for comparison <0.05).
CONCLUSIONS
Compared to the same time-period in 2019, both coronary and structural interventional procedures during COVID-19 epidemic suffered a dramatic decrease in Piedmont, Italy. Organizational change and structured clinical pathways should be created, together with awareness campaigns.
Identifiants
pubmed: 32858138
pii: S0167-5273(20)33655-X
doi: 10.1016/j.ijcard.2020.08.072
pmc: PMC7446645
pii:
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
288-291Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing interest None.
Références
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
Eur Heart J. 2020 May 14;41(19):1852-1853
pubmed: 32297932
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
G Ital Cardiol (Rome). 2020 May;21(5):341-344
pubmed: 32310919
G Ital Cardiol (Rome). 2020 May;21(5):336-340
pubmed: 32310918
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
Catheter Cardiovasc Interv. 2020 Oct 1;96(4):839-843
pubmed: 32223063
Intensive Care Med. 2020 Jun;46(6):1111-1113
pubmed: 32162032
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631
pubmed: 32182131
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):307-311
pubmed: 32191691
JACC Case Rep. 2020 Aug;2(10):1625-1627
pubmed: 32328589
Disaster Med Public Health Prep. 2020 Jun;14(3):372-376
pubmed: 32207676
J Am Coll Cardiol. 2020 Sep 15;76(11):1375-1384
pubmed: 32330544
Emerg Med J. 2020 May;37(5):252-254
pubmed: 32321705
Lancet. 2012 Dec 15;380(9859):2095-128
pubmed: 23245604
N Engl J Med. 2020 Jun 18;382(25):2478-2480
pubmed: 32302081
Occup Med (Lond). 2020 Apr 20;70(2):82-83
pubmed: 32311040